HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
3-propylamino-5-hydroxychroman
Also Known As:
5-hydroxy-3-(N-di-n-propylamino)chroman; NDO 008; NDO-008
Networked:
2
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Pyrans: 130
Benzopyrans: 195
Chromans: 3
3-propylamino-5-hydroxychroman: 2
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Benzopyrans: 195
Chromans: 3
3-propylamino-5-hydroxychroman: 2
Related Diseases
1.
Serotonin Syndrome (Syndrome, Serotonin)
10/01/1998 - "
Both NDO 008 and the two enantiomers of 8-OH-DPAT induced the serotonin syndrome at the dose range that produced inhibition of the PA response, thus, indicating activation of postsynaptic 5-HT1A receptors.
"
2.
Lordosis
07/01/1993 - "
Serotonin (2000 ng) and the 5-HT1A agonists, 8-hydroxy-2-(di-n-propylamino)tetralin [8-OH-DPAT (200 ng)], 5-methoxy-3-(di-n-propylamino)chroman [5-MEO-DPAC (200-2000 ng)] and 5-hydroxy-3-(N-di-n-propylamino)chroman [5-OH-DPAC (200-2000 ng)] inhibited female lordosis behavior within 10 min of the infusion.
"
Related Drugs and Biologics
1.
8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
2.
Serotonin (5 Hydroxytryptamine)
3.
5-methoxy-3-(di-n-propylamino)chroman
4.
hydroxide ion